DJIA 17,804.80 26.65 0.15%
NASDAQ 4,765.38 16.98 0.36%
S&P 500 2,070.65 9.42 0.46%
market minute promo

STEMCELLS, INC. (NASDAQ: STEM)

0.96 -0.03 (-2.90%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

STEM $0.96 -2.90%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $1.00
Previous Close $0.99
Daily Range $0.96 - $1.00
52-Week Range $0.84 - $2.43
Market Cap $66.1M
P/E Ratio -1.98
Dividend (Yield) $0.00 (0.0%)
Volume 558,268
Average Daily Volume 776,595
Current FY EPS -$0.61

Sector

Healthcare

Industry

Drugs

STEMCELLS, INC. (STEM) Description

A biopharmaceutical company that operates in one segment, the development of novel cell-based therapeutics designed to treat human diseases and disorders. Website: http://www.stemcellsinc.com/

News & Commentary

Cloning: A Stem Cell Revolution?

Will the creation of cloned human stem cells create a treatment revolution and a profitable investment?

Monday Sector Laggards: Precious Metals, Biotechnology Stocks

A Timely Interview With BioTime's CEO And His Chief Commercial Officer

StemCells Inc. Faces Tough Times Ahead

StemCells, Inc.: More Downside Risk Ahead

Time To Sell Advanced Cell Technology And Buy StemCells, Inc.

StemCells Starts Phase II Cervical Spinal Cord Injury Study - Analyst Blog

StemCells, Inc: Short-Term Noise Creates Another Buying Opportunity

StemCells' (STEM) CEO Martin McGlynn on Q2 2014 Results - Earnings Call Transcript

StemCells (STEM) Q2 2014 Results - Earnings Call Webcast

Sector Update: Health Care Stocks Falling Late; StemCells Declines Over 10% On Plans for $20 Mln Sto

Sector Update: Health Care Stocks Falling Late; StemCells Declines Over 10% On Plans for $20 Mln Stock Sale

See More STEM News...

STEM's Top Competitors

STEM $0.96 (-2.90%)
Current stock: STEM
AMGN $170.17 (1.00%)
Current stock: AMGN
CELG $117.18 (0.60%)
Current stock: CELG
BIIB $360.67 (1.97%)
Current stock: BIIB